Current Status of Transfer RNA-derived Small RNAs in Cancers
Abstract
of precursor or mature transfer RNAs by specific endonucleases under unfavorable conditions, such as starvation, oxidative stress, hypoxia,
etc. tsRNAs have been found to be abnormally expressed in multiple types of cancers. With the development of science and technology, their
regulatory mechanisms have been gradually discovered. This review summarizes the progress of tsRNAs in cancers of gastrointestinal system,
breast system and reproductive system, and lays the foundation for the diagnosis and treatment of the diseases.
Keywords
Full Text:
PDFReferences
[1] Mikhail G D, Cory B G, Kristi A K, Jonathan D W: Systematic classification of non-coding RNAs by epigenomic similarity. BMC
Bioinformatics 2013(0).
[2] A Gregory M, Rebecca M T, Michael P T: Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev
Mol Cell Biol 2007, 8(3).
[3] Phuong T B H, Ian M C, Linh T T L: MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci 2022, 23(13).
[4] Xin W, Anne R, Martine S, Mo-Fang L: Emerging roles and functional mechanisms of PIWI-interacting RNAs. Nat Rev Mol Cell
Biol, 24(2).
[5] Yang J, Wei T, Yedi Z: Transfer RNA-derived small RNAs: potential applications as novel biomarkers for disease diagnosis and
prognosis. Ann Transl Med 2020, 8(17).
[6] Aleksej D, Vera O, Conor T, Eva J, Dorothea A, Markus H, Steffen K, Stefanie K, Matthias R S: Production and purification of endogenously modified tRNA-derived small RNAs. RNA Biol 2020, 17(8).
[7] Lin X, Jie W, Shaoqing J, Ming C, Rongrong J: Disorders and roles of tsRNA, snoRNA, snRNA and piRNA in cancer. J Med Genet
2022, 59(7).
[8] Fangfang J, Liuqing Y, Weixiang W, Na Y, Shoubin Z, Ping Y, Xi C, Tonghui M, Yanbo W: A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. Mol Cancer 2021, 20(1).
[9] Ting H, Yuexin Z, Guoqin J, Zhixue Y: tsRNA: A Promising Biomarker in Breast Cancer. J Cancer 2024, 15(9).
[10] Alison P K: Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol
Hepatol 2021, 18(7).
[11] Lei J, Chunfu Z, Xihu Q: Expression profile of tRNA-derived fragments in pancreatic cancer. Oncol Lett 2019, 18(3).
[12] Parisa K, Farhad I, Sharmila A, Neal D F, Farin K: Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014, 23(5).
[13] Jing X, Yue W, Xian L, Ming Z, Yang L, Weiwei Z: Clinical value assessment for serum hsa_tsr013526 in the diagnosis of gastric
carcinoma. Environ Toxicol 2024, 39(5).
[14] Xun L, Yu Z, Yang L, Xinliang G, Shaoqing J: A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic
and prognostic biomarker for gastric cancer. Mol Carcinog 2023, 62(10).
[15] Yijing S, Xiuchong Y, Yao R, Zhe L, Yaoyao X, Zhilong Y, Junming G: Global profile of tRNA-derived small RNAs in gastric cancer
patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor. Int J Med Sci 2021, 18(7).
[16] Muhammad A, Mehwish I, Muhammad D, Asmat Ullah K: Awareness and current knowledge of breast cancer. Biol Res 2017, 50(1).
[17] Jingyi W, Ge M, Han G, Xu H, Xinrui M, Xinyang W, Jordee Selvamanee V, Tiansong X, Xiaoan L, Shui W: Circulating tRNAderived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer. NPJ Breast Cancer 2021, 7(1).
[18] Jun Z, Fang W, Yike W, Jinpei L, Xuan Z: Small RNA sequencing reveals a novel tsRNA-26576 mediating tumorigenesis of breast
cancer. Cancer Manag Res 2019, 11(0).
[19] Stephanie L, Marsela B, Amit M O: Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin 2019, 69(4).
[20] Eric Y P, Yang S, Yuke W, Feier Z, Shuangyan T, Yun D, Yiqi D, Haining C, Lei Z, Heng X: Presence and diagnostic value of circulating tsncRNA for ovarian tumor. Mol Cancer 2018, 17(1).
[21] Konstantina P, Paraskevi M, Tobias D, Julia D, Eva O, Sven M, Toon vG, Ioana B, Viktor M, Robert Z et al: tRNA-derived small RNA
3'U-tRF(ValCAC) promotes tumour migration and early progression in ovarian cancer. Eur J Cancer 2023, 180(0).
[22] Menghong Y, Qiwei Z: Sperm tsRNAs and acquired metabolic disorders. J Endocrinol 2016, 230(3).
[23] Qiuyan W, Yao W, Yaoyao X, Xiuchong Y, Shuangshuang Z, Jiaxin G, Zhe L, Guoliang Y, Junming G: Extracellular vesicles-associated tRNA-derived fragments (tRFs): biogenesis, biological functions, and their role as potential biomarkers in human diseases. J
Mol Med (Berl) 2022, 100(5).
DOI: http://dx.doi.org/10.18686/pmr.v2i2.4446
Refbacks
- There are currently no refbacks.
